Menu

RedHill Biopharma Ltd. RDHL

Full chart Compare
Set alert

Price alert · RDHL

All alert types
0.43 USD 0.00 (+0.45%)

At closeNov 6, 2026, 4:00 PM EST

0.42 -0.01 -1.61%

After hours · Nov 6, 4:00 PM ET

0.42 Day range 0.4499
0.388 52-week range 1.40
YTD
-58.46%
1 year
-63.11%

Revenue & Expenses

Other Income → Expenses: $7.50MExpenses → Selling, General & Admin: $6.17MExpenses → Research & Development: $2.02MExpenses → Interest Expense: $19.00KGross Profit → Expenses: $286.00KRevenue → Gross Profit: $286.00KNet Loss → Expenses: $429.00KOther Income$7.50MGross Profit$286.00KNet Loss$429.00KExpenses$8.21MSelling, General & Admin$6.17MResearch & Development$2.02MInterest Expense$19.00KRevenue$286.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

RDHL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
286.00K0061.80M85.76M
286.00K0028.46M36.35M
-7.91M-6.47M-9.55M-42.84M-81.14M
-429.00K-8.27M23.92M-71.67M-97.74M
RDHL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.97M4.62M6.36M35.97M29.47M
25.34M18.04M23.05M158.87M181.19M
21.08M22.73M20.98M207.27M172.31M
1.07M356.00K1.17M122.69M87.81M
4.27M-4.68M2.07M-48.40M8.88M
RDHL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-9.65M-9.37M-35.82M-29.18M-65.05M
1.69M-9.00K4.00K8.30M-8.14M
7.32M8.42M21.44M11.45M73.46M
-5.00K-9.00K-11.00K-198.00K-115.00K
-644.00K-961.00K-14.38M-9.43M275.00K